Mesothelioma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Clinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid Tumours
Conditions:   Clear Cell Renal Cell Carcinoma Metastatic;   TNBC - Triple-Negative Breast Cancer;   Head and Neck Cancer;   Non-small-cell Lung Carcinoma;   Mesothelioma, Malignant Intervention:   Drug: CA9hu-1 Sponsor:   Mabpro, a.s. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2023 Category: Research Source Type: clinical trials